EN
HI

Akums Drugs & Pharmaceuticals Share price

AKUMS

556.85

0.00 (0.00%)
NSE
BSE
Last updated on 16 Jul, 2025 | 09:07 IST
BUYSELL
Today's High

556.85

Today's Low

556.85

52 Week Low

405.00

52 Week High

1175.90

The current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals Chart

Akums Drugs & Pharmaceuticals Share Key Metrics

Volume
1610.00
Market Cap
8764.48 CR
LTQ@LTP
4@556.85
ATP
556.85
Var Margin
18.89 %
Circuit Range
501.2-612.5
Delivery %
78.96 %
Value
8.97 L
ASM/GSM
No
Market Lot
1

Akums Drugs & Pharmaceuticals Futures & Options

Data Not Found

Akums Drugs & Pharmaceuticals Corporate Actions

DateAgenda
2025-07-18-
2025-05-26Audited Results
2025-02-06Quarterly Results
DateEvent TypeAgenda
2025-07-18AGM/EGM-
2025-05-26Board MeetingAudited Results
2025-02-06Board MeetingQuarterly Results

Akums Drugs & Pharmaceuticals News

No Data Found

About Akums Drugs & Pharmaceuticals

NSE : 24715  
BSE : 544222  
ISIN : INE09XN01023  

Our Company was incorporated as a public limited company under the Companies Act 1956 as ‘Akums Drugs and Pharmaceuticals Limited’ pursuant to a certificate of incorporation dated April 19 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19 20 21 sector 6A Haridwar Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22 Sector 6A Sidcul Haridwar Uttarakhand and sterile products at 2345 Sector 6B SIDCUL Haridwar Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48 Sector 6A SIDCUL Haridwar Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47 Sector 6A SIDCUL Haridwar Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar Uttarakhand by Akums Healthcare Limited2022-Plant at 19 20 21 Sector 6A SIDCUL Haridwar Uttarakhand and plant at 2 3 45 Sector 6B SIDCUL Haridwar Uttarakhand accredited European Union-Good Manufacturing Practices qualifying for exports to European markets-Acquisition of a facility in Haridwar Uttarakhand by Akums Healthcare Limited and a facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

Akums Drugs & Pharmaceuticals Management

NamePosition
Mr. Sanjeev Jain Managing Director
Mr. Sandeep Jain Managing Director
Mr. Sanjay Sinha Whole Time Director
Mr. Sunil Kumar Thakur Non Executive Director
Ms. Matangi Gowrishankar Independent Director
Read More

Akums Drugs & Pharmaceuticals FAQs

The Buying Price of Akums Drugs & Pharmaceuticals share is 556.85 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Akums Drugs & Pharmaceuticals share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 25.95. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 2.88. Useful to assess the stock's value relative to its book value.

To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 35.2 & 4.18 with sector averages, along with growth rates and financial metrics.

The Market Cap of Akums Drugs & Pharmaceuticals is 8764.48 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 1175.90 & 405.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.